Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Aug;28(2):326–330. doi: 10.1128/aac.28.2.326

Mechanism of selective inhibition of human cytomegalovirus replication by 1-beta-D-arabinofuranosyl-5-fluorouracil.

S Suzuki, M Saneyoshi, C Nakayama, Y Nishiyama, S Yoshida
PMCID: PMC180241  PMID: 3010844

Abstract

Four kinds of 1-beta-D-arabinofuranosyl-5-halogenouracil were examined for inhibition of human cytomegalovirus (HCMV) and herpes simplex virus type 1 (HSV-1) and 2 (HSV-2) replication. 1-beta-D-Arabinofuranosyl-5-fluorouracil (ara-FU) was the most effective against HCMV, whereas 1-beta-D-arabinofuranosyl-5-bromouracil was the most effective against HSV-1 and HSV-2. The mechanism of action of ara-FU on HCMV replication was also studied. The dTTP pool size in human embryonic fibroblasts was increased 33-fold by HCMV infection. However, treatment with ara-FU decreased the size of the dTTP pool by approximately 50%. On the other hand, 1-beta-D-arabinofuranosyl-5-fluorouracil-5'-triphosphate inhibited HCMV DNA polymerase activity competitively with dTTP. These results suggest that ara-FU acts as a bifunctional inhibitor of HCMV replication. Ara-FU is phosphorylated by cellular thymidine kinase to 1-beta-D-arabinofuranosyl-5-fluorouracil-5'-monophosphate, which inhibits cellular thymidylate synthetase, which in turn decreases the dTTP pool size in infected cells. As the dTTP pool size is reduced, inhibition of viral DNA polymerase by 1-beta-D-arabinofuranosyl-5-fluorouracil-5'-triphosphate becomes more efficient.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colacino J. M., Lopez C. Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents. Antimicrob Agents Chemother. 1983 Oct;24(4):505–508. doi: 10.1128/aac.24.4.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Estes J. E., Huang E. S. Stimulation of cellular thymidine kinases by human cytomegalovirus. J Virol. 1977 Oct;24(1):13–21. doi: 10.1128/jvi.24.1.13-21.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fujiwara Y., Heidelberger C. Fluorinated pyrimidines. 38. The incorporation of 5-trifluoromethyl-2'-deoxyuridine into the deoxyribonucleic acid of vaccinia virus. Mol Pharmacol. 1970 May;6(3):281–291. [PubMed] [Google Scholar]
  4. Mar E. C., Cheng Y. C., Huang E. S. Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother. 1983 Oct;24(4):518–521. doi: 10.1128/aac.24.4.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mar E. C., Patel P. C., Cheng Y. C., Fox J. J., Watanabe K. A., Huang E. S. Effects of certain nucleoside analogues on human cytomegalovirus replication in vitro. J Gen Virol. 1984 Jan;65(Pt 1):47–53. doi: 10.1099/0022-1317-65-1-47. [DOI] [PubMed] [Google Scholar]
  6. Nakayama C., Wataya Y., Meyer R. B., Jr, Santi D. V., Saneyoshi M., Ueda T. Thymidine phosphorylase. Substrate specificity for 5-substituted 2'-deoxyuridines. J Med Chem. 1980 Aug;23(8):962–964. doi: 10.1021/jm00182a029. [DOI] [PubMed] [Google Scholar]
  7. Nakayama C., Wataya Y., Santi D. V., Saneyoshi M., Ueda T. Interaction of 1-(5-phospho-beta-D-arabinofuranosyl)-5-substituted-uracils with thymidylate synthetase: mechanism-based inhibition by 1-(5-phospho-beta-D-arabinosyl)-5-fluorouracil. J Med Chem. 1981 Oct;24(10):1161–1165. doi: 10.1021/jm00142a008. [DOI] [PubMed] [Google Scholar]
  8. Nishiyama Y., Suzuki S., Yamauchi M., Maeno K., Yoshida S. Characterization of an aphidicolin-resistant mutant of herpes simplex virus type 2 which induces an altered viral DNA polymerase. Virology. 1984 May;135(1):87–96. doi: 10.1016/0042-6822(84)90119-3. [DOI] [PubMed] [Google Scholar]
  9. North T. W., Bestwick R. K., Mathews C. K. Detection of activities that interfere with the enzymatic assay of deoxyribonucleoside 5'-triphosphates. J Biol Chem. 1980 Jul 25;255(14):6640–6645. [PubMed] [Google Scholar]
  10. Ono K., Ogasawara M., Ohashi A., Matsukage A., Takahashi T., Nakayama C., Saneyoshi M. Inhibitory effects of various 5-halogenated derivatives of 1-beta-D-arabinofuranosyluracil 5'-triphosphate on DNA polymerases from murine cells and oncornavirus: substituent effects on inhibitory action. Biochemistry. 1982 Mar 2;21(5):1019–1024. doi: 10.1021/bi00534a029. [DOI] [PubMed] [Google Scholar]
  11. Ono K., Ohashi A., Ogasawara M., Matsukage A., Takahashi T., Nakayama C., Saneyoshi M. Inhibition of deoxyribonucleic acid polymerases from murine cells and oncornavirus by 5-alkylated derivatives of 1-beta-D-arabinofuranosyluracil 5'-triphosphate: substituent effects on inhibitory action. Biochemistry. 1981 Aug 18;20(17):5088–5093. doi: 10.1021/bi00520a040. [DOI] [PubMed] [Google Scholar]
  12. Renis H. E. Comparison of cytotoxicity and antiviral activity of 1-beta-D-arabino-furanosyl-5-iodocytosine with related compounds. Cancer Res. 1970 Jan;30(1):189–194. [PubMed] [Google Scholar]
  13. Saneyoshi M., Inomata M., Fukuoka F. Synthetic nucleosides and nucleotides. XI. Facile synthesis and antitumor activities of various 5-fluoropyrimidine nucleosides. Chem Pharm Bull (Tokyo) 1978 Oct;26(10):2990–2997. doi: 10.1248/cpb.26.2990. [DOI] [PubMed] [Google Scholar]
  14. Sidwell R. W., Arnett G., Schabel F. M., Jr In vitro effect of a variety of biologically active compounds on human cytomegalovirus. Chemotherapy. 1972;17(4):259–282. doi: 10.1159/000220858. [DOI] [PubMed] [Google Scholar]
  15. Tanaka K., Yoshioka A., Tanaka S., Wataya Y. An improved method for the quantitative determination of deoxyribonucleoside triphosphates in cell extracts. Anal Biochem. 1984 May 15;139(1):35–41. doi: 10.1016/0003-2697(84)90386-5. [DOI] [PubMed] [Google Scholar]
  16. Tocci M. J., Livelli T. J., Perry H. C., Crumpacker C. S., Field A. K. Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication. Antimicrob Agents Chemother. 1984 Feb;25(2):247–252. doi: 10.1128/aac.25.2.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wingard J. R., Stuart R. K., Saral R., Burns W. H. Activity of trifluorothymidine against cytomegalovirus. Antimicrob Agents Chemother. 1981 Sep;20(3):286–290. doi: 10.1128/aac.20.3.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yamaguchi T., Saneyoshi M. Synthetic nucleosides and nucleotides. XXI. On the synthesis and biological evaluations of 2'-deoxy-alpha-D-ribofuranosyl nucleosides and nucleotides. Chem Pharm Bull (Tokyo) 1984 Apr;32(4):1441–1450. doi: 10.1248/cpb.32.1441. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES